Amgen’s race to recharge the pulse of R&D: National Science Week

Science is rarely a straight line. It’s a tangle of breakthroughs and bottlenecks, quiet wins and loud frustrations. Coinciding with National Science Week, Cae Tolman, Country Senior Medical Director, and Lynda Paton, Senior Manager, Development Operations at Amgen ANZ, share an inside view of the forces shaping the Australian R&D ecosystem.

In this Health Industry Hub podcast, the duo chart Amgen’s growing R&D footprint, reveal why a long-promised National One Stop Shop remains stuck in limbo, and unpack the power of local partnerships driving next-generation cancer research.

Alongside the momentum, they speak frankly about the long shadow of delays, like the still-unrealised National One Stop Shop and the urgency of embedding patient voices at the heart of every clinical trial.

Amgen’s leap into the top 10 patent filers in Australia, fuelled by AI-driven drug discovery and manufacturing efficiency, is more than a milestone. The next five years will demand bold alignment between industry and government to keep pace with the science and meet the growing expectations of patients.

In reimagining healthcare across the entire patient journey, Health Industry Hub^TM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry Hub^TM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.